Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MA

Mark Andrews — 19 Patents

Pfizer: 11 patents #437 of 5,153Top 9%
CLCdt Oxford Limited: 3 patents #9 of 29Top 35%
UAUnion Therapeutics A/S: 3 patents #6 of 35Top 20%
LALeo Pharma A/S: 2 patents #31 of 102Top 35%
Ashford, GB: #10 of 513 inventorsTop 2%
Overall (All Time): #229,345 of 4,157,543Top 6%
19 Patents All Time
Mark Andrews has been granted 19 US patents while listed as an inventor at Pfizer. The first was granted in 2002 and the most recent in August 2024. Mark Andrews ranks #229,345 of 4,157,543 US inventors in our database (top 5.5%). Patent records list Mark Andrews in Ashford, GB.

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12065429 Small molecule modulators of IL-17 Mogens Larsen, Alan Stuart JESSIMAN, Patrick Stephen Johnson, Kevin Neil Dack 2024-08-20
11981681 Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors Daniel Rodriguez Greve, Bjarne Nørremark 2024-05-14
11384096 Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors Daniel Rodriguez Greve, Bjarne Nørremark 2022-07-12
11377425 Small molecule modulators of IL-17 Kevin Neil Dack, Xifu Liang, Mogens Larsen, Alan Stuart JESSIMAN, Mia Nørreskov Burhardt +3 more 2022-07-05
11292799 Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors Daniel Rodriguez Greve, Jens Larsen 2022-04-05
9163021 Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors Sharanjeet Kaur Bagal, David Brown, Karl Richard Gibson, Wolfgang Klute, Inaki Morao +5 more 2015-10-20 $537,604,000
8883321 Polymerizable compositions and organic light-emitting devices containing them Annette Steudel, Alan Mosley, Kai Look 2014-11-11
8846698 Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors Sharanjeet Kaur Bagal, Karl Richard Gibson, Kiyoyuki Omoto, Thomas Ryckmans, Sarah Elizabeth Skerratt +1 more 2014-09-30 $281,207,000
8592403 Diazepine and diazocane compounds as MC4 agonists Christopher Gordon Barber 2013-11-26 $220,822,000
8138188 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines Alan Daniel Brown, Mark Ian Lansdell, Nicholas William Summerhill 2012-03-20 $311,110,000
7928099 Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists Julian Blagg, Paul Brennan, Paul Vincent Fish, R. Ian Storer, Gavin Alistair Whitlock 2011-04-19 $184,395,000
7829203 Polymerisable compositions and organic light-emitting devices containing them Annette Steudel, Alan Mosley, Kal Look 2010-11-09
7736534 Phosphorescent compositions and organic light emitting devices containing them Neil Maxted, Annette Steudel, Alan Mosley, Kai Look, Nigel Male 2010-06-15
7378436 Compounds Paul Vincent Fish, Michael J. Fray, Alan Stobie, Florian Wakenhut, Gavin Alistair Whitlock +2 more 2008-05-27 $99,152,000
7129234 Phenyl heterocyclyl ethers Mavis Adam, Geoffrey E. Gymer, David Hepworth, Harry Howard, Donald Middleton +1 more 2006-10-31 $291,859,000
6800652 Diaryl compounds David Hepworth, Donald Middleton 2004-10-05 $392,072,000
6630504 Phenoxyphenylheterocyclyl derivatives as SSRIs David Hepworth, Donald Middleton, Alan Stobie 2003-10-07 $307,545,000
6610747 Phenoxybenzylamine derivatives as SSRIs Mavis Adam, Mark Elliott, Geoffrey E. Gymer, David Hepworth, Harry Howard +2 more 2003-08-26 $177,412,000
6448293 Diphenyl ether compounds useful in therapy David Hepworth, Donald Middleton, Alan Stobie 2002-09-10 $252,411,000